These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27055064)

  • 1. External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.
    Nikolayevskyy V; Hillemann D; Richter E; Ahmed N; van der Werf MJ; Kodmon C; Drobniewski F; Ruesch-Gerdes S;
    PLoS One; 2016; 11(4):e0152926. PubMed ID: 27055064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.
    Drobniewski FA; Nikolayevskyy V; Hoffner S; Pogoryelova O; Manissero D; Ozin AJ
    Euro Surveill; 2008 Mar; 13(12):. PubMed ID: 18761994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area.
    Anthony RM; Tagliani E; Nikolayevskyy V; de Zwaan R; Mulder A; Kamst M; Ködmön C; van der Werf MJ; Cirillo D; van Soolingen D;
    Microbiol Spectr; 2023 Feb; 11(1):e0224422. PubMed ID: 36475728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Union training programme for tuberculosis laboratory experts: design, contribution and future direction.
    Raftery P; Ködmön C; van der Werf MJ; Nikolayevskyy V
    BMC Health Serv Res; 2020 May; 20(1):413. PubMed ID: 32393246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data.
    Cole MJ; Quaye N; Jacobsson S; Day M; Fagan E; Ison C; Pitt R; Seaton S; Woodford N; Stary A; Pleininger S; Crucitti T; Hunjak B; Maikanti P; Hoffmann S; Viktorova J; Buder S; Kohl P; Tzelepi E; Siatravani E; Balla E; Hauksdóttir GS; Rose L; Stefanelli P; Carannante A; Pakarna G; Mifsud F; Cassar RZ; Linde I; Bergheim T; Steinbakk M; Mlynarczyk-Bonikowska B; Borrego MJ; Shepherd J; Pavlik P; Jeverica S; Vazquez J; Abad R; Weiss S; Spiteri G; Unemo M
    BMC Infect Dis; 2019 Mar; 19(1):281. PubMed ID: 30909883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV; Malakhov VN; Hoffner SE; Haile M; Wright A
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1294-300. PubMed ID: 19793436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.
    Ssengooba W; Gelderbloem SJ; Mboowa G; Wajja A; Namaganda C; Musoke P; Mayanja-Kizza H; Joloba ML
    Health Res Policy Syst; 2015 Jan; 13():4. PubMed ID: 25589057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot external quality assurance programme for line-probe assay detection of anti-tuberculosis drug resistance.
    Leung KL; Yip CW; Tang HS; Lai YW; Lam TK; Kam KM
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):262-6. PubMed ID: 23244351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.
    Hillemann D; Hoffner S; Cirillo D; Drobniewski F; Richter E; Rüsch-Gerdes S; ; ;
    PLoS One; 2013; 8(10):e76765. PubMed ID: 24146924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
    Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study.
    Nikolayevskyy V; Maurer FP; Holicka Y; Taylor L; Liddy H; Kranzer K
    J Antimicrob Chemother; 2019 May; 74(5):1288-1294. PubMed ID: 30753511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection - China, 2014-2019.
    Ou X; Xia H; Wang S; Zhao B; Fan J; Song Y; Zhou Y; Zheng Y; Zhao Y
    China CDC Wkly; 2021 Mar; 3(12):247-251. PubMed ID: 34594859
    [No Abstract]   [Full Text] [Related]  

  • 14. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis Laboratory Diagnosis Quality Assurance among Public Health Facilities in West Amhara Region, Ethiopia.
    Shiferaw MB; Hailu HA; Fola AA; Derebe MM; Kebede AT; Kebede AA; Emiru MA; Gelaw ZD
    PLoS One; 2015; 10(9):e0138488. PubMed ID: 26376438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality assessment of microscopic examination in tuberculosis diagnostic laboratories: a preliminary study].
    Simşek H; Ceyhan I; Tarhan G; Güner U
    Mikrobiyol Bul; 2010 Oct; 44(4):561-9. PubMed ID: 21063968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.
    Ködmön C; Hollo V; Huitric E; Amato-Gauci A; Manissero D
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae.
    Slotved HC; Sheppard CL; Dalby T; van der Ende A; Fry NK; Morfeldt E; Nyholm O; Rokney A; Ron M; Siira L; Scott KJ; Smith A; Thom L; Toropainen M; Vestrheim DF
    Sci Rep; 2017 Oct; 7(1):13280. PubMed ID: 29038446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urgent needs in fostering neglected tropical diseases (NTDs) laboratory capacity in WHO Western Pacific Region: results from the external quality assessment on NTDs diagnosis in 2012-2015.
    Lu Y; Gonzales G; Chen SH; Li H; Cai YC; Chu YH; Ai L; Chen MX; Chen HN; Chen JX
    Infect Dis Poverty; 2017 Jun; 6(1):106. PubMed ID: 28592266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory diagnosis of paediatric tuberculosis in the European Union/European Economic Area: analysis of routine laboratory data, 2007 to 2011.
    Sanchini A; Fiebig L; Drobniewski F; Haas W; Richter E; Katalinic-Jankovic V; Pimkina E; Skenders G; Cirillo DM; ; Balabanova Y
    Euro Surveill; 2014 Mar; 19(11):. PubMed ID: 24679723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.